ACON, founded in 1995, is leading the way in developing, manufacturing, and marketing high quality In-Vitro Diagnostic (IVD) products globally, possessing strong R&D and cutting-edge technology, independent Intellectual Property, state-of-the-art facilities, complete customer service support and preeminent quality management system.
As a global enterprise, ACON currently has 2 operating facilities: ACON Biotech (Hangzhou) Co., Ltd. located in Hangzhou, China; ACON Laboratories Inc. located in San Diego, USA.
Our current product lines include Rapid Test, Diabetes Care, Clinical Chemistry, Immunoassay and Molecular Diagnostics. Relying on its broadly-stretched sales network, ACON products are available in more than 150 countries for public or private healthcare providers, institutions, NGOs, individuals, etc.
ACON is US FDA registered and EU ISO 13485:2016 certified. ACON complies with CFDA and passed a variety of authoritative on-site audits from different nations, including US FDA, Germany TUV SUD, France LNE, Brazil ANVISA, Korea FDA, etc.